Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 vs placebo in advanced hepatocellular carcinoma after sorafenib failure
jRCT2080220889Phase 3
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hepatocellular carcinoma (HCC) comparing S-1 with Placebo (2 arms).
02
Drugs
tegafur
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCT2080220889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220889.